Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 48 for:    test | ( Map: Gambia )

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination (MASSIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03576313
Recruitment Status : Recruiting
First Posted : July 3, 2018
Last Update Posted : November 29, 2018
Sponsor:
Collaborators:
Institute of Tropical Medicine, Belgium
National Malaria Control Programme, The Gambia
Liverpool School of Tropical Medicine
Radboud University
University of Durham
Imperial College London
Information provided by (Responsible Party):
London School of Hygiene and Tropical Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2021